Table 5.
Summary of repeated measures analysis of core body temperature AUEC(0,12 h)
| XEN-D501 vs. placebo | ||||
|---|---|---|---|---|
| Day 1 | Day 2 | Day 7 | Day 14 | |
| Cohort 1: 1 mg twice daily vs. placebo | ||||
| Treatment difference | 3.39 | 4.68 | −0.29 | 1.80 |
| 95% CI | 1.80, 4.98 | 2.90, 6.45 | −2.08, 1.51 | 0.10, 3.50 |
| P value | <0.0001 | <0.0001 | 0.75 | 0.04 |
| Cohort 2: 2.5 mg twice daily vs. placebo | ||||
| Treatment difference | 5.70 | 5.65 | 2.29 | 2.22 |
| 95% CI | 4.45, 6.95 | 4.27, 7.04 | 1.01, 3.56 | 0.94, 3.51 |
| P value | <0.0001 | <0.0001 | 0.0006 | 0.0010 |
| Cohort 3: 5 mg twice daily vs. placebo | ||||
| Treatment difference | 8.86 | 6.12 | 3.75 | 2.92 |
| 95% CI | 7.50, 10.22 | 4.73, 7.51 | 2.35, 5.15 | 1.56, 4.28 |
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 |